Prior to the pandemic, decentralized clinical trials were not widely utilized and were mainly performed by innovation groups at big pharma companies or as targeted special projects. In an Outsourcing-Pharma article, Melissa Nezos, Firma’s VP of Clinical Operations, explains how the pandemic increased the need to bring the study to the patient. She says Firma is collaborating with more sponsors on protocols to offer more virtual clinical trials elements through home visits.
Read the Outsourcing-Pharma article HERE to learn more about how Home Trials Visits can help decentralized trials succeed.
